Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
MOTS-C
EfficacyHigh
Studies0
Participants0
StatusAvailable

MOTS-C

Mitochondrial Open Reading Frame of the 12S rRNA-c

MOTS-C is a 16-amino acid mitochondrial-derived peptide (MDP) encoded by mitochondrial DNA. It plays a crucial role in regulating metabolic homeostasis, glucose metabolism, and insulin sensitivity. MOTS-C has shown promising therapeutic potential in aging, diabetes management, cardiovascular health, and physical performance enhancement. Currently in research phase with no clinical approval.

Clinical Benefits

Enhanced mitochondrial function and biogenesis
Improved glucose metabolism and insulin sensitivity
Age-related physical performance improvement
Cardiovascular protection and heart health
Metabolic stress resistance and homeostasis
AMPK pathway activation for energy regulation

Mechanism of Action

MOTS-C functions as a mitochondrial-nuclear communication peptide that activates AMP-activated protein kinase (AMPK) signaling pathways. It modulates the folate/methionine cycle and enhances cellular stress resistance. MOTS-C interacts with nuclear genes to regulate metabolic homeostasis, particularly glucose metabolism and insulin sensitivity. The peptide promotes mitochondrial biogenesis, improves oxidative metabolism, and provides cytoprotection against age-related cellular damage.

Key Action: Mitochondrial-derived peptide - activates AMPK pathways to enhance cellular metabolism and longevity

Proven Results

0%
Maximum Weight Loss
Clinical research data
0%
Diabetes Risk Reduction
Clinical research data
0
Total Participants
Research studies
0%
CV Risk Reduction
Clinical data

Medical Disclaimer

MOTS-C is an experimental peptide not approved by the FDA for therapeutic use. It is banned by WADA for athletic competition. All information is for educational purposes only and should not constitute medical advice. Consult healthcare professionals before considering any peptide therapy. Long-term safety and efficacy in humans remain unknown.